Страна: Россия

Сфера деятельности: Бизнес

Company Profile Merit Medical Systems, Inc. (Nasdaq: MMSI) is a leading manufacturer of medical devices used in diagnostic and interventional cardiology and radiology procedures. Its primary products consist of inflation devices used in angioplasty, stent placement and discography; diagnostic and therapeutic catheters used for various procedures in cardiology and radiology; guide wires used to place balloon angioplasty catheters within a patient's coronary arteries; products used to manage and monitor the administration of contrast and other fluid solutions during diagnostic and therapeutic procedures; thrombolytic catheters and fluid dispensing systems; angiography accessories; and standard and custom angiography kits. Headquartered in South Jordan, Utah, a suburb of Salt Lake City, Merit employs approximately 1,700 people worldwide. Merit markets its products in the United States through a 75-person direct sales force and has broadened its presence in Europe and the world through a network of 20 direct sales people and a number of distributors. These highly trained individuals and organizations market Merit's products both domestically and internationally by calling directly on physicians and clinicians who will be using the products in hospitals and clinics worldwide. The Company has expanded from a small manufacturing facility in Salt Lake City to two separate facilities in the metropolitan area. It also has a manufacturing facility in Galway, Ireland, enabling Merit to provide quality sub-components for its products and better distribution to European accounts. Merit also has a catheter manufacturing facility located in Angleton, Texas, a procedure tray and pack manufacturing facility in Richmond, Virginia and a customer service and distribution center in Maastricht, The Netherlands. The Company has achieved a world leadership position in inflation devices and hemostasis valves and is renowned for its product innovation, customer service and product quality. Learn More about the Corporate Governance. COMPANY HISTORY Merit Medical Systems, Inc. (NASDAQ, MMSI) was founded in 1987 by Fred P. Lampropoulos. Merit develops, manufactures and markets single-use medical devices primarily for diagnosing and treating cardiovascular and vascular disease. Merit has been successful in introducing and marketing innovative, high-quality products through its expertise in new product design and its capabilities in injection and insert molding of plastics; the application of its proprietary electronic and sensor-based technologies; and wire, extrusion and catheter technologies. Merit also develops and markets embolotherapeutic products for the treatment of uterine fibroids, hypervascularized tumors, and arteriovenous malformations. Embolotherapy procedures are primarily performed by interventional radiologists and use bioengineered microspheres to create targeted vascular occlusion and drug delivery. The Company is utilizing its competitive advantages and technologies to develop and offer products that address a wide range of needs related to cardiology and radiology procedures performed in hospitals. Sales are made primarily to U.S. hospitals through a direct sales force. The Company markets its products in over 60 countries worldwide, utilizing a direct sales force in Europe, and distributors for the remainder of the world.